Search clinical trials for: IL17/ IL-1β

Total 38 results

University of New Mexico

Completed

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

Lichen Planus | Lichen Planopilaris | Lichen Planus Scalp

United States
Centre Hospitalier Universitaire de Nice

Recruiting

IL17 Rate and Spondyloarthritis

Spondylarthritis

France
Sohag University

Recruiting

Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP) (microRNAITP)

Primary Immune Thrombocytopenia

Egypt
Centre Hospitalier Universitaire de Nīmes

Recruiting

Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17 (RESPOND-IL17)

Axial Spondyloarthritis

France
Novartis Pharmaceuticals

Completed

The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients

Dry Eye

United States
Peking Union Medical College Hospital

Recruiting

An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients

Psoriatic Arthritis

China
Novartis Pharmaceuticals

Completed

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States
Copenhagen University Hospital, Hvidovre

Not yet recruiting

The Effect of Anti-IL17 on Airway Hyperresponsiveness and Resistance

Asthma
Radboud University Medical Center
University Hospital, Ghent; ZonMw: The Netherlands Organisation for Health... and other collaborators

Active, not recruiting

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio)

Psoriasis | Psoriasis Vulgaris

Netherlands, Belgium
Sohag University

Completed

Gene Polymorphism of IL17 and IL 23 (COVID 19IL17)

COVID-19 Respiratory Infection

Egypt
Sohag University

Not yet recruiting

IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage

Systemic Lupus Erythematosus

Egypt
Mayo Clinic
Eli Lilly and Company

Completed

Ixekizumab in the Treatment of Bullous Pemphigoid

Bullous Pemphigoid | Pemphigoid

United States
Novartis Pharmaceuticals

Completed

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Chronic Plaque-type Psoriasis

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis (REMISSIOn)

Psoriasis | Microbial Colonization
Academisch Medisch Centrum - Universiteit van Amsterdam...
Novartis

Completed

Mechanism of Action of Anti-IL17 Therapy in Peripheral Spondyloarthritis (MoA aIL-17)

Spondylarthropathies

Netherlands
Kahramanmaras Sutcu Imam University

Completed

The Effect of Acupuncture on the Treatment of Endovenous Ablation on Pain, IL17 and IL 23

Pain | Interleukin | Vessels; Varicose

Turkey
Xenthera, Inc.

Not yet recruiting

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Advanced Solid Tumor | Metastatic Solid Tumor
Novartis Pharmaceuticals

Completed

Safety and Efficacy of AIN457 in Noninfectious Uveitis

Non-infectious Uveitis

United States, Germany
Alexandria University

Not yet recruiting

The Effect of Pomegranate Peel, German Chamomile or Their Combination on Gingivitis

Gingivitis

Egypt
Olatec Therapeutics LLC

Recruiting

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Arthritis | Joint Pain | Gout | Gout Flare | Gouty Arthritis | Acute Gout Flare | Gout Attack

United States, Spain, France
Phoenicis Therapeutics

Recruiting

Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects (CANOPY-1)

Non-small Cell Lung Cancer

United States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD

Adult Onset Still's Disease

Japan
Novartis Pharmaceuticals

Terminated

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy (CANOPY-2)

Non-Small-Cell Lung

Germany, Spain, Belgium, Canada, Netherlands, Italy, Taiwan, Argentina, Australia, Israel, Japan, Lebanon, France, Poland, United States, Jordan, Korea, Republic of, China, Brazil, Czechia, Greece, Russian Federation, Denmark, Hungary, ... and more
Priscilla Hsue, MD
Massachusetts General Hospital

Completed

Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk

Cardiovascular Disease | HIV

United States
Medical University of Bialystok

Completed

Biomarkers of Metabolic Obesity.

Obesity

Poland
Applied Science Private University

Completed

The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm

Cytokine Storm | Cytokines

Jordan
University Hospital, Basel, Switzerland
Novartis; Swiss National Science Foundation

Completed

Canakinumab in Patients With COVID-19 and Type 2 Diabetes (CanCovDia)

Coronavirus Infection | Diabetes Mellitus, Type 2

Switzerland
The Cleveland Clinic
National Institute of Mental Health (NIMH); Case Western Reserve University; Van...

Completed

Biomarkers as Predictors of Suicidal Risk in Adolescents

Suicidal Ideation | Suicide, Attempted | Suicide | Suicidal Intention

United States
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever. (β-SPECIFIC 3)

Systemic Juvenile Idiopathic Arthritis

Italy, United States, Belgium, Germany, Greece, Russian Federation, Turkey, Spain, France, Israel, Canada, Hungary, Switzerland, United Kingdom, Brazil, Austria, Sweden, Netherlands, Argentina, Peru, Poland
University Hospital, Basel, Switzerland

Completed

Postprandial Hypoglycemia in Patients After Bariatric Surgery With Empagliflozin and Anakinra - The Hypo-BEAR-Study (Hypo-BEAR)

Bariatric Surgery | Postprandial Hypoglycemia | Late Dumping Syndrome

Switzerland
Novartis Pharmaceuticals
International Maternal Pediatric Adolescent AIDS Clinical Trials Group; Southwest...

Terminated

Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) (β-SPECIFIC 1)

Systemic Juvenile Idiopathic Arthritis

United States, Argentina, Canada, Switzerland, Germany, United Kingdom, Israel, South Africa, Belgium, Greece, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru, Denmark
Groupe Hospitalier Paris Saint Joseph
Institut Pasteur; Agency for Science, Technology and Research

Completed

Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis (CASPASEs)

Severe Sepsis

France
Tehran University of Medical Sciences

Unknown

The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients

Migraine
University Hospital Inselspital, Berne
Eastern Virginia Medical School

Completed

Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation

Menopause | Vaginal Atrophy

Switzerland
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma

Hepatitis B | Hepatocellular Carcinoma | Chronic Liver Disease

Taiwan
Novartis Pharmaceuticals
Pediatric Rheumatology International Trials Organization

Completed

Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (β-SPECIFIC 2)

Systemic Juvenile Idiopathic Arthritis With Active Flare

United States, Argentina, Canada, Switzerland, Germany, Israel, South Africa, Belgium, Italy, Spain, France, Brazil, Turkey, Hungary, Poland, Norway, Sweden, Netherlands, Peru
Radboud University Medical Center
Novartis

Completed

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

Schnitzler Syndrome

Netherlands

Search clinical trials for: IL17/ IL-1β

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations